Healthcare
Multiples buys ICICI Venture's stake in Vikram Hospital
Multiples Alternate Asset Management has bought a 64% stake in Bangalore-based Vikram Hospital from ICICI Venture Funds Management, and also infused direct capital for debt repayment.
Standard Chartered boosts stake as India's Fortis moves to cut debt
Standard Chartered Private Equity (SCPE) will invest a further $13.5 million in hospital chain Fortis Healthcare through a preferential allotment of shares, taking its total holding to around 2.7%.
Legend Capital joins funding round for heart valve implant maker
Legend Capital has participated in a $62.5 million Series C round of funding for Munich-based JenaValve Technology, a manufacturer of valve systems used to treat heart conditions. The company intends to apply to market products in China.
IndiaVenture eyes $25m first close on healthcare fund
IndiaVenture Advisors (IVA), the PE arm of Indian healthcare company Piramal Enterprises, expects to reach a first close at around INR1.5 billion ($25 million) next month on IndiaVenture Trust Fund II, which has a full target of INR10 billion.
China medical devices: Climbing the value chain
Driven by government policy, China's medical devices industry is growing rapidly and VC capital is flowing in. Picking winners requires a keen eye for new technology and potential distribution obstacles
Riverside buys controlling stake in NZ animal drug delivery group
Riverside has acquired a controlling interest in Hamilton-based animal drug delivery company Simcro for a undisclosed sum.
Qiming promotes Nisa Leung to managing partner
Qiming Venture Partners has promoted Nisa Leung, the head of its healthcare practice, to managing partner.
Blackstone set for partial exit as Emcure Pharma files for IPO
The Blackstone Group will make a partial exit from its 2006 investment in India's Emcure Pharmaceuticals as the company targets a INR3 billion ($50.4 million) IPO.
ChrysCapital-backed Intas Pharma files for IPO
ChrysCapital Partners will exit the 10.16% stake held by Fund III in Ahmedabad-based formulations maker Intas Pharmaceuticals via an upcoming IPO. Another 6.25% stake will continue to be held by the PE firm's fifth fund.
KKR-backed GenesisCare taps US debt markets
GenesisCare, a healthcare business controlled by KKR, has become the latest Australian PE-backed company to refinance its debt via the US high-yield market. A string of corporates are taking advantage of strong liquidity in the US leveraged market, where...
Quadria hires Rajesh Singhal to boost India coverage
Quadria Capital has appointed Rajesh Singhal as principal managing partner. He will take responsibility for the education and healthcare portfolio companies in India Build-Out Fund I, a vehicle acquired from Milestone Religare Investment Advisors three...
SEAVI Advent reaches $125m first close on Fund VI
SEAVI Advent Private Equity, the Asian arm of Advent International, has reached a first close of $125 million on its six fund - SEAVI Advent Equity Fund VI. Commitments came from high net worth individuals, corporate institutions and family offices, while...
Indian pharma firm Cipla launches VC unit
Cipla, an India-based generic drug maker, has set up a VC arm – Cipla Ventures – to invest in biotechnology, medical devices and new chemical entities.
Asian Healthcare Fund invests in Wellspring clinic chain
Delhi-based Asian Healthcare Fund (AHF) has invested in Wellspring Healthcare, which runs eight primary care clinics in Mumbai under the Healthspring Community Medical Centres brand. Financial details of the deal were not disclosed.
China's GSR leads restructuring round for Mirabilis Medica
China-focused GSR Ventures is leading a $7 million restructuring round for Mirabilis Medica with a view to helping the company expand its footprint outside the US.
China.com to sell LP stake in New Horizon fund to AlpInvest
China.com, a news agency listed on Hong Kong Growth Enterprise Market (GEM) board, will sell its entire stake in New Horizon Capital IV to AlpInvest Partners for $516,000.
DEG invests $12m in Indian hospital chain
German Investment and Development (DEG), a development finance institution, has invested INR700 million ($12 million) in the Ivy Healthcare Group which runs a chain of super specialty hospitals in the north Indian state of Punjab.
Quadrant-backed Virtus Health jumps 9% on ASX debut
Shares in Virtus Health, an Australian in-vitro fertilization company backed by Quadrant Private Equity, closed up 9% at A$6.20 on its first day of trading on the Australian Securities Exchange. The IPO had been priced at the top end of the indicative...
IFC to support BioVeda's $200m China fund
International Financial Corp.(IFC), the World Bank investment arm, plans to commit up to $20 million to the latest fund launched by healthcare-focused firm BioVeda China Fund (BVCF).
Apax makes $22.6m from Apollo Hospitals partial exit
Apax Partners has made another partial exit from India’s Apollo Hospitals, generating proceeds of of INR1.28 billion ($22.6 million) via the National Stock Exchange.
CITIC PE completes $370m 3SBio take-private
Chinese biotechnology firm 3SBio will delist from NASDAQ after shareholders voted in favor of a privatization bid from a group led by the company’s CEO and CITIC Private Equity. The deal, which values 3SBio at $370 million, is the eighth successful PE-backed...
Temasek-backed healthcare firm HCG acquires majority stake in BACC
HealthCare Global Enterprises (HCG), an Indian cancer treatment specialist backed by Temasek Holdings, has acquired a majority stake in Bangalore Assisted Conception Centre (BACC), a leading provider of fertility care. Details of the transaction were...
Korea's Access Bio goes public, STIC PE expects 5x return
STIC Private Equity has made a partial exit from Korean biotech firm Access Bio after the company went public on the KOSDAQ exchange. The PE firm sold shares in two tranches – one just before the IPO and one during it – and has generated a money multiple...
India Value Fund-backed Manipal invests in Ankur Healthcare
India Value Fund-backed Manipal Health Enterprises has committed INR400 million ($7.27 million) to Ankur Healthcare, which specializes in infertility treatment.